Detail page

Knowledge Web

Person

Matthias Eder (1959-)

Arzt

Name	Matthias Eder
Time	1959- (Date of birth and death)
Place	Trier (Geburtsort) Hannover (Wirkungsort) Deutschland
Gender	männlich
Academic degree	Prof. Dr. med.
Profession	Arzt (characteristic profession) Internist Onkologe Hämatologe
Related	Medizinische Hochschule Hannover (1999-) Psychologie; Philosophie; Medizin (Studienfach)
Further information	Habil. Fach Innere Medizin an der Medizinischen Hochschule Hannover
Record type	Person
GND-Identifier	133667006
Record ID	133667006
Involved in show all Correction: Long term results of a prospective multicenter observational study on the use of anti-human T-lymphocyte immunoglobulin (ATLG) in unrelated donor transplantation (ATOS study) Comparison of fludarabine/melphalan (FluMel) with fludarabine/melphalan/BCNU or thiotepa (FBM/FTM) in patients with AML in first complete remission undergoing allogeneic hematopoietic stem cell transplantation – a registry study on behalf of the EBMT Acute Leukemia Working Party Correction: Long term results of a prospective multicenter observational study on the use of anti-human T-lymphocyte immunoglobulin (ATLG) in unrelated donor transplantation (ATOS study) Development and preclinical characterization of a novel radiotheranostic EphA2-targeting bicyclic peptide Goldnanopartikel : Eine Plattform für multimodale Diagnostik und Therapie in der experimentellen Nuklearmedizin Long term results of a prospective multicenter obervational study on the use of anti-human T-lymphocyte immunoglobulin (ATLG) in unrelated donor transplantation (ATOS study) Outcomes of haploidentical transplants with PT-CY versus 10/10 MUD transplants with ATG in Germany The impact of pre-transplantation diabetes and obesity on acute graft-versus-host disease, relapse and death after allogeneic hematopoietic cell transplantation: a study from the EBMT Transplant Complications Working Party Comparison of fludarabine/melphalan (FluMel) with fludarabine/melphalan/BCNU or thiotepa (FBM/FTM) in patients with AML in first complete remission undergoing allogeneic hematopoietic stem cell transplantation – a registry study on behalf of the EBMT Acute Leukemia Working Party Refined chelator spacer moieties ameliorate the pharmacokinetics of PSMA-617 Leukemogenic potency of the novel FLT3-N676K mutant Differential expression of miR-17~92 identifies BCL2 as a therapeutic target in BCR-ABL-positive B-lineage acute lymphoblastic leukemia Sequential anti-cytomegalovirus response monitoring may allow prediction of cytomegalovirus reactivation after allogeneic stem cell transplantation Signaltransduktion durch den Rezeptor für Granulozyten-Makrophagen-Kolonien-stimulierenden Faktor (GM-CSF) in myeloischen Zellen Wirkung der rekombinanten Zytokine GM-CSF und IL-3 auf Blasten akuter nicht lymphatischer Leukämien in vitro

Please note

The beta version does not yet contain all functions and information of the DNB portal catalogue. If you are missing information or want to order a medium, please visit the page in the DNB portal catalogue via the following link:

Katalog der Deutschen Nationalbibliothek

Matthias Eder (1959-)

Correction: Long term results of a prospective multicenter observational study on the use of anti-human T-lymphocyte immunoglobulin (ATLG) in unrelated donor transplantation (ATOS study)

Comparison of fludarabine/melphalan (FluMel) with fludarabine/melphalan/BCNU or thiotepa (FBM/FTM) in patients with AML in first complete remission undergoing allogeneic hematopoietic stem cell transplantation – a registry study on behalf of the EBMT Acute Leukemia Working Party

Correction: Long term results of a prospective multicenter observational study on the use of anti-human T-lymphocyte immunoglobulin (ATLG) in unrelated donor transplantation (ATOS study)

Development and preclinical characterization of a novel radiotheranostic EphA2-targeting bicyclic peptide

Goldnanopartikel : Eine Plattform für multimodale Diagnostik und Therapie in der experimentellen Nuklearmedizin

Long term results of a prospective multicenter obervational study on the use of anti-human T-lymphocyte immunoglobulin (ATLG) in unrelated donor transplantation (ATOS study)

Outcomes of haploidentical transplants with PT-CY versus 10/10 MUD transplants with ATG in Germany

The impact of pre-transplantation diabetes and obesity on acute graft-versus-host disease, relapse and death after allogeneic hematopoietic cell transplantation: a study from the EBMT Transplant Complications Working Party

Comparison of fludarabine/melphalan (FluMel) with fludarabine/melphalan/BCNU or thiotepa (FBM/FTM) in patients with AML in first complete remission undergoing allogeneic hematopoietic stem cell transplantation – a registry study on behalf of the EBMT Acute Leukemia Working Party

Refined chelator spacer moieties ameliorate the pharmacokinetics of PSMA-617

Leukemogenic potency of the novel FLT3-N676K mutant

Differential expression of miR-17~92 identifies BCL2 as a therapeutic target in BCR-ABL-positive B-lineage acute lymphoblastic leukemia

Sequential anti-cytomegalovirus response monitoring may allow prediction of cytomegalovirus reactivation after allogeneic stem cell transplantation

Signaltransduktion durch den Rezeptor für Granulozyten-Makrophagen-Kolonien-stimulierenden Faktor (GM-CSF) in myeloischen Zellen

Wirkung der rekombinanten Zytokine GM-CSF und IL-3 auf Blasten akuter nicht lymphatischer Leukämien in vitro